Compare AUTL & NAMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | NAMM |
|---|---|---|
| Founded | 2014 | 2024 |
| Country | United Kingdom | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.6M | 410.8M |
| IPO Year | 2018 | N/A |
| Metric | AUTL | NAMM |
|---|---|---|
| Price | $1.55 | $1.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 305.6K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $51,128,000.00 | ★ $80,348,000.00 |
| Revenue This Year | $658.11 | N/A |
| Revenue Next Year | $91.34 | $109.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 406.67 | 9.52 |
| 52 Week Low | $1.11 | $1.27 |
| 52 Week High | $3.11 | $55.00 |
| Indicator | AUTL | NAMM |
|---|---|---|
| Relative Strength Index (RSI) | 58.56 | N/A |
| Support Level | $1.31 | N/A |
| Resistance Level | $1.61 | N/A |
| Average True Range (ATR) | 0.09 | 0.00 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 85.37 | 0.00 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.